Flora Peyvandi Selected Research

Fibrinogen (Factor I)

1/2022	Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium.
1/2022	A homozygous duplication of the <I>FGG</i> exon 8-intron 8 junction causes congenital afibrinogenemia. Lessons learned from the study of a large consanguineous Turkish family.
11/2021	Anti-TNF-α Treatment Reduces the Baseline Procoagulant Imbalance of Patients With Inflammatory Bowel Diseases.
3/2021	Efficacy and safety of fibrinogen concentrate for on-demand treatment of bleeding and surgical prophylaxis in paediatric patients with congenital fibrinogen deficiency.
1/2021	Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia.
1/2021	Pharmacokinetics, surrogate efficacy and safety evaluations of a new human plasma-derived fibrinogen concentrate (FIB Grifols) in adult patients with congenital afibrinogenemia.
1/2020	Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients.
1/2020	Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.
1/2019	Treatment of rare factor deficiencies other than hemophilia.
1/2018	Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Flora Peyvandi Research Topics

Disease

66	Hemorrhage 03/2022 - 05/2002
57	Hemophilia A (Haemophilia) 03/2022 - 05/2002
34	Thrombotic Thrombocytopenic Purpura 01/2022 - 04/2003
21	Thrombosis (Thrombus) 01/2022 - 09/2005
17	COVID-19 08/2022 - 01/2020
17	Afibrinogenemia (Fibrinogen Deficiency) 01/2022 - 08/2002
14	acquired Thrombotic thrombocytopenic purpura 01/2021 - 08/2005
13	von Willebrand Diseases (von Willebrand's Disease) 12/2022 - 07/2011
11	Thrombocytopenia (Thrombopenia) 08/2022 - 11/2004
11	Thrombotic Microangiopathies 01/2021 - 04/2003
8	Thrombophilia 01/2022 - 07/2005
8	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 02/2012
7	Myocardial Infarction 01/2016 - 08/2006
6	Infections 08/2022 - 01/2007
6	Stroke (Strokes) 01/2020 - 02/2010
6	Coronary Artery Disease (Coronary Atherosclerosis) 10/2016 - 04/2009
5	Pneumonia (Pneumonitis) 05/2022 - 08/2013
5	Inflammation (Inflammations) 01/2022 - 02/2016
5	Fibrosis (Cirrhosis) 01/2022 - 07/2014
5	Type 3 von Willebrand Disease 01/2022 - 05/2003
5	Hemolytic Anemia 01/2019 - 11/2004
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2015
4	Venous Thromboembolism 01/2021 - 08/2013
4	Hypertension (High Blood Pressure) 01/2021 - 04/2016
4	Genetic Predisposition to Disease (Genetic Predisposition) 10/2020 - 08/2010
4	Inherited Blood Coagulation Disorders 02/2019 - 09/2004
3	Respiratory Insufficiency (Respiratory Failure) 06/2022 - 10/2020
3	Sepsis (Septicemia) 05/2022 - 02/2010
3	Joint Diseases (Joint Disease) 03/2022 - 09/2018
3	Hemarthrosis 03/2022 - 01/2020
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 08/2007
3	Spontaneous Abortion (Miscarriage) 04/2020 - 11/2014
3	Menorrhagia 01/2020 - 07/2009
3	Liver Diseases (Liver Disease) 01/2020 - 09/2018
3	Hemophilia B (Haemophilia B) 01/2020 - 05/2015
3	Ischemic Stroke 01/2016 - 08/2010
3	Familial Multiple Coagulation Factor Deficiency I 06/2009 - 08/2005
3	Factor V Deficiency 10/2008 - 01/2003
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 08/2022 - 08/2005
2	Chronic Pain 03/2022 - 01/2021
2	Type 1 von Willebrand Disease 03/2022 - 01/2021
2	Non-alcoholic Fatty Liver Disease 01/2022 - 07/2014
2	Drug-Related Side Effects and Adverse Reactions 10/2021 - 02/2018
2	Hypersensitivity (Allergy) 09/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

38	Factor VIII (Coagulation Factor VIII)IBA 01/2022 - 05/2002
32	thiamine triphosphorate (TTP)IBA 11/2020 - 04/2003
29	von Willebrand FactorIBA 12/2022 - 04/2003
26	Fibrinogen (Factor I)FDA Link 01/2022 - 08/2002
18	Blood Coagulation Factors (Coagulation Factor)IBA 03/2022 - 10/2002
13	Thrombin FDA Link 01/2022 - 10/2002
12	AntibodiesIBA 06/2022 - 08/2005
11	AutoantibodiesIBA 01/2022 - 11/2004
11	Factor V (Coagulation Factor V)IBA 11/2019 - 10/2002
10	emicizumabIBA 09/2021 - 01/2019
9	AnticoagulantsIBA 01/2022 - 12/2012
9	Hemostatics (Antihemorrhagics)IBA 01/2021 - 02/2012
9	Metalloproteases (Metalloproteinases)IBA 10/2020 - 08/2005
8	AntigensIBA 03/2020 - 04/2003
7	Proteins (Proteins, Gene)FDA Link 02/2021 - 08/2005
7	DisintegrinsIBA 10/2020 - 08/2005
7	ThrombospondinsIBA 10/2020 - 08/2005
7	Factor X (Stuart Factor)IBA 01/2020 - 10/2002
6	Biomarkers (Surrogate Marker)IBA 06/2022 - 02/2008
6	ADAMTS13 ProteinIBA 01/2019 - 04/2003
5	Complement System Proteins (Complement)IBA 11/2021 - 11/2012
5	Monoclonal AntibodiesIBA 09/2021 - 12/2016
5	caplacizumabIBA 01/2021 - 01/2016
5	Prothrombin (Factor II)IBA 01/2019 - 08/2002
5	Vitamin K FDA Link 01/2018 - 06/2009
5	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 07/2005
4	Immunoglobulin G (IgG)IBA 06/2022 - 08/2005
4	BESIBA 01/2022 - 01/2018
4	VaccinesIBA 01/2022 - 10/2021
4	NucleotidesIBA 01/2021 - 01/2016
4	CoagulantsIBA 01/2021 - 07/2012
4	RivaroxabanIBA 01/2021 - 11/2013
4	EnzymesIBA 11/2019 - 08/2005
4	Pharmaceutical PreparationsIBA 09/2018 - 10/2012
4	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2017 - 05/2002
4	Factor VII (Proconvertin)IBA 07/2011 - 10/2002
3	FibrinIBA 01/2022 - 10/2016
3	fibrin fragment D (D-dimer)IBA 01/2022 - 01/2020
3	C-Reactive ProteinIBA 11/2021 - 02/2021
3	COVID-19 VaccinesIBA 10/2021 - 01/2021
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021 - 10/2016
3	Neutralizing AntibodiesIBA 01/2017 - 01/2016
3	Dronabinol (THC)FDA LinkGeneric 10/2016 - 01/2015
3	omega-Chloroacetophenone (Mace)IBA 10/2016 - 01/2015
3	Protein CIBA 07/2014 - 08/2013
3	Peptide Hydrolases (Proteases)FDA Link 02/2008 - 04/2003
3	BBeta fibrinogenIBA 10/2003 - 08/2002
2	Oxygen (Dioxygen)IBA 06/2022 - 02/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022 - 01/2020
2	Rituximab (Mabthera)FDA Link 01/2022 - 01/2018
2	recombinant FVIIa (rFVIIa)FDA Link 01/2022 - 07/2018
2	ElementsIBA 10/2021 - 01/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 09/2021 - 09/2012

Therapy/Procedure

40	Therapeutics 06/2022 - 12/2008
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2016 - 01/2013